Christopher Cheng

TL;DR: With gradual Westernisation, many Asian countries may be losing their cultural protective factors and acquiring high- risk ones, and a better understanding of how these factors interact to cause prostate cancer through further studies with a multi-ethnic perspective will facilitate appropriate public health strategies to minimise high-risk factors and maintain Protective factors and keep prostate cancer at bay.

TL;DR: Several prognostic factors can help discriminate between favourable and unfavourable RCC phenotypes, and several clinical, pathologic, and biologic markers have been tested and validated and they are used in predictive and prognostic models.

TL;DR: Bipolar T URP using the TURIS system is clinically comparable to monopolar TURP at 1 yr with an improved safety profile and the IPSS and Q(max) improvements were comparable between the two groups at 12 mo of follow-up.

TL;DR: A summary of the Second International Consultation on Bladder Cancer recommendations on the diagnosis and treatment options for non-muscle-invasive urothelial cancer of the bladder (NMIBC) using an evidence-based approach is presented.

TL;DR: This study demonstrates that inactivating mutations of KDM6A, which are common in urothelial bladder carcinoma, are potentially targetable by inhibiting EZH2 and small-molecule inhibitors of EZh2 were effective against KDM 6A-null bladder cancer in multiple mouse models.